Q1 2026 13F Filing Dates: Exact SEC Deadlines and What Comes Out When
The SEC's current Form 13F FAQ lists Friday, May 15, 2026 as the Q1 2026 filing deadline. Here is the full date map, what investors should expect to arrive first, and how to track filings without refreshing EDGAR all day.
If you want the cleanest answer to “when do Q1 2026 13F filings come out?”, the SEC now gives it directly. In the agency's updated Form 13F FAQ, the deadline for the quarter ended March 31, 2026 is listed as Friday, May 15, 2026. That date matters because 13F season gets noisy fast once the first large managers hit EDGAR. The best preparation is to know the exact calendar in advance and decide which filings you care about before the rush starts.
The exact Q1 2026 deadline
Form 13F is due 45 days after quarter-end. For Q1 2026, that means holdings as of March 31, 2026 must be filed by May 15, 2026. The SEC's current FAQ also lists the next deadlines in the same sequence: August 14, 2026 for Q2 2026, November 16, 2026 for Q3 2026, and February 16, 2027 for Q4 2026 because the normal February 14 date falls on a weekend and holiday-adjusted schedule.
What tends to arrive first
The deadline tells you the last day a filer can submit, not the exact minute a specific manager will file. In practice, large, highly watched managers often cluster near the start of the window, while the full population fills in through the deadline. That is why it is usually more useful to follow a watchlist of managers such as Berkshire, Bridgewater, Millennium, and Tiger Global than to wait for headlines after everyone else has already reacted.
What 13F does and does not tell you
A 13F shows long U.S.-listed equity positions and certain related securities as of quarter-end. It does not show shorts, most international holdings, or a manager's real-time positioning. That is why the most useful workflow is comparison: what was added, what was sold, and whether the top of the book became more or less concentrated.
How to track the season without living inside EDGAR
You can absolutely search EDGAR directly, but the raw experience is slow if you are following multiple managers. A cleaner approach is to keep a watchlist, check the research hub for preview pieces before the deadline, and use a filings product to surface the actual changes once the reports land. The point is not speed for its own sake. It is having the comparison layer ready when the data drops.
Q&A
When is the Q1 2026 13F deadline?
Friday, May 15, 2026.
Why is the Q4 2026 deadline February 16, 2027 instead of February 14?
Because the SEC's published schedule rolls deadlines that fall on weekends or holidays to the next business day.
What should I prepare before May 15, 2026?
A manager watchlist, a short list of themes you care about, and a way to compare each new filing against the prior quarter quickly.
More Educational Guides
Related Research
Explore all researchNuveen’s Q4 2025 filing stayed large-cap and AI-heavy at the top, but the more revealing addition was a sizable fixed-income sleeve through NXUS and NHYB. The next filing will show whether those credit and bond ETFs remain central or fade back out.
Apr 17, 2026
Principal’s Q4 2025 filing looked slightly weaker on headline AUM, but the internal rotation was more revealing: Brookfield became a top-ten position, Netflix surged, and the fund cut back in parts of real estate. The next filing will show whether that shift keeps going.
Apr 17, 2026
Fisher’s Q4 2025 filing was still packed with mega-cap tech, but the bigger tell was a giant Treasury and investment-grade corporate bond sleeve built through IEF and VCIT. The next filing will show whether that duration bet was tactical or structural.
Apr 17, 2026
Dodge & Cox’s Q4 2025 filing barely moved on headline AUM, but the underlying changes were more interesting: fresh positions in Brookfield, TransUnion and PDD inside a still-diversified value book. The next filing will show whether those adds were conviction moves or just incremental reshuffling.
Apr 17, 2026
AQR’s Q4 2025 filing kept expanding, with AUM rising to $190.63B, 69 new names, and a dramatic Bristol Myers build inside an already broad book. The next filing will show whether the quant giant keeps pressing this expansion or starts normalizing the roster again.
Apr 17, 2026